Farther Finance Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.4K Buy
868
+39
+5% +$1.77K ﹤0.01% 3303
2026
Q2
$23.9K Buy
829
+8
+1% +$174 ﹤0.01% 3848
2026
Q1
$14.7K Buy
821
+56
+7% +$1.06K ﹤0.01% 3864
2025
Q4
$14.4K Sell
765
-97
-11% -$1.63K ﹤0.01% 3657
2025
Q3
$12.5K Buy
862
+653
+312% +$9.31K ﹤0.01% 3330
2025
Q2
$4.08K Buy
209
+69
+49% +$1.23K ﹤0.01% 3436
2025
Q1
$2.48K Sell
140
-7,466
-98% -$161K ﹤0.01% 3296
2024
Q4
$163K Hold
7,606
– – 0.01% 1078
2024
Q3
$237K Hold
7,606
– – 0.01% 930
2024
Q2
$117K Buy
7,606
+150
+2% +$1.81K 0.01% 1068
2024
Q1
$76.9K Sell
7,456
-3
-0% -$30 ﹤0.01% 1036
2023
Q4
$89.5K Buy
7,459
+143
+2% +$1.17K 0.01% 837
2023
Q3
$51.2K Buy
+7,316
New +$67.6K 0.01% 765

Other funds holding CDNA

Farther Finance Advisors's CDNA Position: Q3 2026 in Review

Farther Finance Advisors increased its CareDx (CDNA) stake by 4.7% in Q3 2026, buying an estimated $1.77K and bringing the position to 868 shares worth $56.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3303.

Farther Finance Advisors first reported a position in CDNA in Q3 2023 and has held it in 13 quarters since. The position peaked at $237K in Q3 2024. 4 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Farther Finance Advisors held 868 shares of CareDx worth $56.4K as of Q3 2026.
  • Farther Finance Advisors bought 39 CareDx shares in Q3 2026, an estimated $1.77K.
  • CareDx made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3303 holding.
  • Farther Finance Advisors first reported a position in CareDx in Q3 2023 and has held it in 13 quarters since.
  • Farther Finance Advisors's CareDx position peaked at $237K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.